Hearing Loss Trial, Recruiting NCT07691853 Sponsor: Universitair Ziekenhuis Brussel Condition: Hearing Loss
Back to Hearing Loss

Hearing Loss Trial, Recruiting

NCT07691853
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 years or older
  • People who had normal hearing at some point in their life before losing it, and now have severe to profound hearing loss in the ear(s) that received the implant
  • People who have had a CT scan of their cochlear implant electrode after surgery, with the scan results available
  • People who have been fitted with a MED-EL brand cochlear implant
  • People whose implant uses a Flex28, FlexSoft, or Standard electrode (specific implant part types)
  • People who use a SONNET 2 or RONDO 3 sound processor (the external device worn with the implant)
  • People who have been using their cochlear implant for at least 6 months
  • People whose implant electrode has been inserted deeply enough into the inner ear — specifically, reaching at least 540 degrees of the spiral shape inside the ear (confirm with trial site)
  • People who have at least 10 active sound channels switched on in their implant
  • People who wear a hearing aid in the opposite ear to the implant, and that hearing aid is properly fitted
  • People who are fluent in the language used at the trial centre
  • People who have signed and dated a consent form before any trial procedures begin

Who may not be able to join:

  • People who do not meet all of the inclusion criteria listed above
  • People implanted with older MED-EL implant models known as C40+, C40X, or C40C
  • People who have an Auditory Brainstem Implant (a different type of hearing implant that connects to the brainstem rather than the inner ear) or a Split electrode array
  • People where, in the opinion of the investigating doctor, participation would put them at greater risk or prevent them from completing the trial fully

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 12 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Universitair Ziekenhuis Brussel
Registry
ClinicalTrials.gov
Start date
1 July 2024
Est. completion
1 December 2026

Where this trial is recruiting

🇧🇪 Belgium

Primary endpoints

Speech recognition test in quiet

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov